PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
17.97%
Revenue growth 50-75% of CRON.TO's 26.40%. Martin Whitman would scrutinize if slower growth is temporary.
25.11%
Cost growth above 1.5x CRON.TO's 12.84%. Michael Burry would check for structural cost disadvantages.
-9.53%
Gross profit decline while CRON.TO shows 366.16% growth. Joel Greenblatt would examine competitive position.
-23.31%
Margin decline while CRON.TO shows 310.57% expansion. Joel Greenblatt would examine competitive position.
188.72%
R&D growth above 1.5x CRON.TO's 1.30%. Michael Burry would check for spending discipline.
-32.89%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
48.76%
Marketing expense growth while CRON.TO reduces spending. John Neff would investigate strategic advantage.
156.00%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
-8.86%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
10.87%
Total costs growth while CRON.TO reduces costs. John Neff would investigate differences.
41.73%
Interest expense change of 41.73% while CRON.TO maintains costs. Bruce Berkowitz would investigate control.
48.75%
D&A growth 50-75% of CRON.TO's 69.64%. Bruce Berkowitz would examine asset strategy.
94.19%
EBITDA growth while CRON.TO declines. John Neff would investigate advantages.
131.61%
EBITDA margin growth 50-75% of CRON.TO's 192.34%. Martin Whitman would scrutinize operations.
-37.46%
Both companies show declining income. Martin Whitman would check industry conditions.
-16.53%
Both companies show margin pressure. Martin Whitman would check industry conditions.
152.56%
Other expenses growth while CRON.TO reduces costs. John Neff would investigate differences.
113.77%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
111.67%
Pre-tax margin growth while CRON.TO declines. John Neff would investigate advantages.
-1.72%
Both companies reducing tax expense. Martin Whitman would check patterns.
111.86%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
110.06%
Net margin growth while CRON.TO declines. John Neff would investigate advantages.
116.82%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
116.82%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
68.21%
Share count reduction below 50% of CRON.TO's 0.01%. Michael Burry would check for concerns.
68.21%
Diluted share increase while CRON.TO reduces shares. John Neff would investigate differences.